Seegene

Family of multiplex real-time PCR assays that detect and differentiate multiple pathogens in one test, covering respiratory, reproductive-tract and gastrointestinal infections and multidrug-resistant organisms (MDRO).

Modular automated PCR testing system that integrates sample preprocessing, nucleic acid extraction, amplification and result processing.

Statistical data platform that aggregates worldwide PCR testing data in real time and shows regional infection trends, pathogen-specific positivity rates and co-infection patterns.

Technology-sharing program launched in 2023 that provides syndromic PCR assay technology, the SGDDS automated development tool and CURECA to partners in each country, which set up local companies to develop and supply diagnostics.

Seegene USA received U.S. FDA Emergency Use Authorization for the Allplex HSV-1&2/VZV/MPXV Assay, which simultaneously detects and differentiates HSV-1 and 2, varicella-zoster virus (VZV) and mpox virus (MPXV).

Launched the Global Million Clinical Study to evaluate the clinical utility of syndromic PCR testing across one million tests, starting in Korea and expanding to institutions abroad, initially covering reproductive-tract, respiratory and gastrointestinal infections.

Launched the Allplex MDRO Assay, which detects multidrug-resistant organisms and resistance genes in a single run, in Europe with CE marking under the EU IVDR.